Childhood invasive pneumococcal disease caused by non-7-valent pneumococcal vaccine (PCV7) serotypes under partial immunization in Taiwan

Journal of the Formosan Medical Association

Volumn 112, Issue 9, 2013, Pages 561-568

  Shen, Ching Fen ^a,b   Wang, Shih Min ^b,c   Lee, Kuan Hsien ^a   Ho, Tzong Shiann ^b   Liu, Ching Chuan ^a,c  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Conjugate pneumococcal vaccine; Epidemiology; Invasive pneumococcal disease; Streptococcus pneumoniae

Indexed keywords

C REACTIVE PROTEIN; CEFTRIAXONE; PENICILLIN DERIVATIVE; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIUM ISOLATE; BONE AND JOINT INFECTIONS; CHILD; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; FEMALE; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFANT; INTENSIVE CARE UNIT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MENINGITIS; PARTIAL IMMUNIZATION; PERITONITIS; PLEURA EMPYEMA; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; RESPIRATORY FAILURE; SCHOOL CHILD; SEROTYPE; SEROTYPING; STREPTOCOCCUS PNEUMONIA; TAIWAN; TERTIARY HEALTH CARE; VACCINATION;

CONJUGATE PNEUMOCOCCAL VACCINE; EPIDEMIOLOGY; INVASIVE PNEUMOCOCCAL DISEASE; STREPTOCOCCUS PNEUMONIAE;

CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION; INFANT; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING;

EID: 84884701193     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2013.05.015     Document Type: Article

References (34)

1. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000, 106:362-366. American Academy of Pediatrics, Committee on Infectious DiseasesCommittee on Infectious Diseases.
2. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000, 49:1-35. Preventing pneumococcal disease among infants and young children.
3. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction-eight states, 1998-2005. MMWR Morb Mortal Wkly Rep 2008, 57:144-148.
4. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005, 54:893-897.
5. Isaacman D.J., McIntosh E.D., Reinert R.R. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 2010, 14:e197-e209.
6. Reinert R., Jacobs M.R., Kaplan S.L. Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine 2010, 28:4249-4259.
7. Gonzalez B.E., Hulten K.G., Lamberth L., Kaplan S.L., Mason E.O. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J 2006, 25:301-305.
8. Byington C.L., Samore M.H., Stoddard G.J., Barlow S., Daly J., Korgenski K., et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 2005, 41:21-29.
9. Byington C.L., Korgenski K., Daly J., Ampoto K., Pavia A., Mason E.O., et al. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 2006, 25:250-254.
10. Hsieh Y.C., Lin P.Y., Chiu C.H., Huang Y.C., Chang K.Y., Liao C.H., et al. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: Emergence of serotype 19A with high invasive potential. Vaccine 2009, 27:5513-5518.
11. Huang Y.C., Ho Y.H., Hsieh Y.C., Lin H.C., Hwang K.P., Chang L.Y., et al. A 6-year retrospective epidemiology study of pediatric pneumococcal pneumonia in Taiwan. J Formos Med Assoc 2008, 12:945-951.
12. Chen Y.Y., Yao S.M., Chou C.Y., Chang Y.C., Shen P.W., Huang C.T., et al. Surveillance of invasive Streptococcus pneumoniae in Taiwan, 2002-2003. J Med Microbiol 2006, 55:1109-1114.
13. Lin W.J., Lo W.T., Chou C.Y., Chen Y.Y., Tsai S.Y., Chu M.L., et al. Antimicrobial resistance patterns and serotype distribution of invasive Streptococcus pneumoniae isolates from children in Taiwan from 1999 to 2004. Diagn Microbiol Infect Dis 2006, 56:189-196.
14. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003, 348:1737-1746.
15. Singleton R.J., Hennessy T.W., Bulkow L.R., Hammitt L.L., Zulz T., Hurlburt D.A., et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007, 297:1784-1792.
16. Bender J.M., Ampofo K., Korgenski K., Daly J., Pavia A.T., Mason E.O., et al. Pneumococcal necrotizing pneumonia in Utah: Does serotype matter?. Clin Infect Dis 2008, 46:1346-1352.
17. Fletcher M., Leeming J., Cartwright K., Finn A. Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2006, 25:559-560.
18. Vesikari T., Wysocki J., Chevallier B., Karvonen A., Czajka H., Arsene J.P., et al. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Pediatr Infect Dis J 2009, 28(Suppl 4):S66-S76.
19. Butler J.C., Breiman R.F., Campbell J.F., Lipman H.B., Broome C.V., Facklam R.R. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 1993, 270:1826-1831.
20. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000, 19:187-195.
21. O'Brien K.L., Moulton L.H., Reid R., Weatherholtz R., Oski J., Brown L., et al. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet 2003, 362:355-361.
22. Shinefield H.R., Black S., Ray P., Chang I., Lewis N., Fireman B., et al. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J 1999, 18:757-763.
23. Ghaffar F., Barton T., Lozano J., Muniz L.S., Hicks P., Gan V., et al. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clin Infect Dis 2004, 39:930-938.
24. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24-59 months who are not completely vaccinated. MMWR Morb Mortal Wkly Rep 2008, 57:343-344.
25. Liao W.H., Lin S.H., Lai C.C., Tan C.K., Liao C.H., Huang Y.T., et al. Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan. Eur J Clin Microbiol Infect Dis 2010, 29:489-492.
26. Hennessy T.W., Singleton R.J., Bulkow L.R., Bruden D.L., Hurlburt D.A., Parks D., et al. Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska natives: progress towards elimination of a health disparity. Vaccine 2005, 23:5464-5473.
27. Millar E.V., Watt J.P., Bronsdon M.A., Dllas J., Reid J., Santosham M., et al. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members. Clin Infect Dis 2008, 47:989-996.
28. Hicks L.A., Harrison L.H., Flannery B., Hadler J.L., Schaffner W., Craig A.S., et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007, 196:1346-1354.
29. Munoz-Almagro C., Jordan I., Gene A., Latorre C., Garcia-Garcia J.J., Pallares R. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2008, 46:174-182.
30. Roc He P.W., Krause V., Cook H., Barralet J., Coleman D., Sweeny A., et al. Invasive pneumococcal disease in Australia, 2006. Commun Dis Intell 2008, 32:18-30.
31. Lu C.Y., Huang L.M. How many is enough? Will conjugated pneumococcal vaccines with more serotypes and fewer doses work better?. J Formos Med Assoc 2011, 110:67-69.
32. Salleras L., Dominguez A., Ciruela P., Izquierdo C., Navas E., Torner N., et al. Changes in serotypes causing invasive pneumococcal disease (2005-2007 vs. 1997-1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine. Clin Microbiol Infect 2009, 15:997-1001.
33. Aguiar S.I., Serrano I., Pinto F.R., Melo-Cristino J., Ramirez M. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine. Clin Microbiol Infect 2008, 14:835-843.
34. Wu P.S., Huang L.M., Chang I.S., Lu C.Y., Shao P.L., Tsai F.Y., et al. The epidemiology of hospitalized children with pneumococcal/lobar pneumonia and empyema from 1997 to 2004 in Taiwan. Eur J Pediatr 2010, 169:861-866.